): This proposal, in response to NIH RFA: CA-97-008, describes the competing renewal application for a Clinical Oncology Research Career Development Program at Memorial Sloan-Kettering Cancer Center. The objective of this training program is to provide clinical oncology trainees with advanced laboratory and clinical investigation skills enabling them to develop full-time academic careers focused on moving basic findings in molecular and cellular biology, as well as immunology and pharmacology, from the research laboratory into hypothesis driven-clinical trials or investiga-tions. The training program will be directed by its Principal Investigator, Ethan Dmitrovsky, M.D. with the support and interaction of the chairpersons of the five clinical departments at Memorial Hospital: Medicine, Surgery, Radiation Oncology, Pediatrics, and Neurology. Mentors are selected to direct the research activities of the current and future trainees. The curriculum includes laboratory research training, opportunities to develop and execute translational clinical trials, educational and didactic seminars and lectures, and instruction in the preparation of grant applications. The requested number of trainees is three yearly, the level funded in the current NIH K12-CA0A12 entitled: Clinical and Molecular Cancer Research Training (CMCRT) Program. Trainees may remain in the program for up to five years gaining the required advanced training in laboratory-based research needed to initiate successful independent academic research careers at this Center or elsewhere. As summarized in this application, all past trainees have: (1) initiated an independent research career already supported through peer-review funds, (2) published their work in peer-review journals, or (3) obtained an independent academic faculty position. The applicants are eager to continue this training program at Memorial Sloan-Kettering Cancer Center because of the highly interactive clinical and basic research environment available to contribute to the advanced training of future physician-scientists in clinical oncology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
3K12CA001712-10S1
Application #
6643906
Study Section
Special Emphasis Panel (ZCA1 (01))
Program Officer
Lei, Ming
Project Start
1992-09-11
Project End
2003-06-30
Budget Start
2002-09-01
Budget End
2003-06-30
Support Year
10
Fiscal Year
2002
Total Cost
$168,678
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Vazquez, Alexei; Tedeschi, Philip M; Bertino, Joseph R (2013) Overexpression of the mitochondrial folate and glycine-serine pathway: a new determinant of methotrexate selectivity in tumors. Cancer Res 73:478-82
Ferrone, Cristina R; Perales, Miguel-Angel; Goldberg, Stacie M et al. (2006) Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains. Clin Cancer Res 12:5511-9
Srinivasan, Roopa; Houghton, Alan N; Wolchok, Jedd D (2002) Induction of autoantibodies against tyrosinase-related proteins following DNA vaccination: unexpected reactivity to a protein paralogue. Cancer Immun 2:8
Perales, Miguel-Angel; Wolchok, Jedd D (2002) Melanoma vaccines. Cancer Invest 20:1012-26
Perales, Miguel-Angel; Fantuzzi, Giamila; Goldberg, Stacie M et al. (2002) GM-CSF DNA induces specific patterns of cytokines and chemokines in the skin: implications for DNA vaccines. Cytokines Cell Mol Ther 7:125-33
Perales, Miguel-Angel; Blachere, Nathalie E; Engelhorn, Manuel E et al. (2002) Strategies to overcome immune ignorance and tolerance. Semin Cancer Biol 12:63-71
Noy, A; Verma, R; Glenn, M et al. (2001) Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol. Blood 97:1929-36
Wolchok, J D; Srinivasan, R; Perales, M A et al. (2001) Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigens. Cancer Immun 1:9
Araten, D J; Nafa, K; Pakdeesuwan, K et al. (1999) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U S A 96:5209-14
Lonardo, F; Rusch, V; Langenfeld, J et al. (1999) Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. Cancer Res 59:2470-6

Showing the most recent 10 out of 21 publications